#

Search

Blog


<< Go Back
Pfizer

Revenue up 4% at Rs 573 crore (Bloomberg estimate: Rs 552 crore) Ebitda up 10% at Rs 182 crore (Bloomberg estimate: Rs 177 crore) Ebitda margin at 31.8% Vs 30.1% (Bloomberg estimate: 32%) Net profit up 3% at Rs 130 crore (Bloomberg estimate: Rs 130 crore) The board recommended a final dividend of Rs 35 per share for the fiscal 2023. It also announced a a special dividend of Rs 5 a share in view of the gain on sale of business undertaking at Thane.